Corrigendum: Usefulness and Potential Pitfalls of Long-Acting Growth Hormone Analogues [PDF]
Frontiers in Endocrinology, 2021 Kevin C. J. Yuen +3 more
doaj +2 more sources
Corrigendum: Guidance for the treatment of adult growth hormone deficiency with somapacitan, a long-acting growth hormone preparation [PDF]
Frontiers in Endocrinology, 2023 Martin Bidlingmaier +6 more
doaj +2 more sources
Long-acting growth hormones: innovations in treatment and guidance on patient selection in pediatric growth hormone deficiency [PDF]
Annals of Pediatric Endocrinology & MetabolismLong-acting growth hormones (LAGHs) represent a significant advancement in the treatment of pediatric GH deficiency, offering an alternative to daily recombinant human GH (rhGH) therapy.
Chiara Rodaro +3 more
doaj +4 more sources
Molecules, 2019 The long-acting growth hormone (LAGH) is a promising alternative biopharmaceutical to treat growth hormone (GH) deficiency in children, and it was developed using a variety of technologies by several pharmaceutical companies. Most LAGH preparations, such
Wenrong Yao +8 more
doaj +3 more sources
First Clinical Study on Long-Acting Growth Hormone Therapy in Children with Turner Sydrome [PDF]
Hormone and Metabolic Research, 2022 Chun Gong, Lijun Fan, Beibei Zhang
exaly +2 more sources
Preclinical Investigations of a Novel PEGylated Long-Acting Human Growth Hormone
Drug Design, Development and TherapyJun Wang,1,2 He Wang,1,2 Rong Wang,1,2 Yu Zhuang,1,2 Chenyang Jiang,1,2 Baixue Zhao,1,2 Zhen Xu,1,2 Bruce Yong Ma1,2 1Zonhon Biopharma Institute, Inc., Changzhou, Jiangsu, People’s Republic of China; 2Jiangsu Engineering Research Center for Precision ...
Wang J +7 more
doaj +3 more sources
Retraction: Effect of weekly long-acting growth hormone replacement therapy compared to daily growth hormone on children with short stature: a meta-analysis [PDF]
Frontiers in Endocrinology, 2023 Frontiers Editorial Office
doaj +2 more sources
Effects of different doses of long-acting growth hormone in treating children with growth hormone deficiency. [PDF]
World J Clin Cases, 2023 β cells are the main cells responsible for the hypoglycemic function of pancreatic islets, and the insulin secreted by these cells is the only hormone that lowers blood glucose levels in the human body. β cells are regulated by various factors, among which neurotransmitters make an important contribution.
Xia W, Wang T, Pan JY.
europepmc +3 more sources
KBG Syndrome: A Case Report and Longitudinal Assessment of Long‐Acting Recombinant Human Growth Hormone Therapy [PDF]
Clinical Case ReportsThis case analysis examines the clinical data, molecular genetic testing results, and 20‐month clinical data of long‐acting recombinant human growth hormone (rhGH) treatment in a child with KBG syndrome (KBGS). The child exhibited a c.1591delG frameshift
Hui Nan, Pu Zhang, Jing Qian
doaj +2 more sources
Long-Acting Growth Hormone Preparations and Their Use in Children with Growth Hormone Deficiency [PDF]
Hormone Research in Paediatrics, 2022 <b><i>Background:</i></b> Daily recombinant human growth hormone (rhGH) is approved and marketed worldwide to treat children and adults with GH deficiency and other conditions. Efficacy of rhGH therapy is influenced by several variables.
Pampanini, Valentina +3 more
openaire +3 more sources